Filter
525
Filtered Results: 525
Text search:
HPV
Featured
Recommendations
62
New Publications
157
Language
Document type
No document type
277
Guidelines
87
Studies & Reports
56
Manuals
32
Fact sheets
32
Strategic & Response Plan
18
Training Material
9
Infographics
6
Brochures
4
Situation Updates
2
App
1
Online Courses
1
Countries / Regions
India
23
Kenya
19
Global
19
South Africa
19
Tanzania
15
Zambia
13
Nepal
9
Malawi
9
Germany
9
Uganda
9
Ethiopia
9
Lesotho
8
Nigeria
8
Philippines
8
Cambodia
8
Western and Central Europe
8
Paraguay
8
Ghana
7
Sierra Leone
7
Rwanda
7
Africa
7
Latin America and the Carribbean
7
Vietnam
7
Namibia
6
Liberia
6
Laos
5
Burkina Faso
5
Zimbabwe
5
Mozambique
4
Congo, Democratic Republic of
4
Middle East and North Africa
4
East and Southern Africa
4
Bangladesh
4
Brazil
4
Botswana
4
Myanmar / Burma
4
Cameroon
3
South–East Asia Region
3
Eastern Europe
3
Switzerland
2
El Salvador
2
Benin
2
Syria
2
Senegal
2
Burundi
2
Eastern Europe and Central Asia
2
Argentina
2
Yemen
2
Indonesia
2
Colombia
1
Thailand
1
Ukraine
1
Togo
1
Chile
1
Niger
1
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Russia
1
Central African Republic
1
Chad
1
South Sudan
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
247
Clinical Guidelines
76
Women & Child Health
53
Public Health
23
Capacity Building
7
Key Resources
5
Pharmacy & Technologies
5
Toolboxes
HIV
73
COVID-19
46
Refugee
24
TB
13
Caregiver
13
Pharmacy
12
NCDs
11
AMR
9
Global Health Education
8
NTDs
7
Mental Health
6
Conflict
5
Disability
3
Ebola & Marburg
3
Health Financing Toolbox
3
Planetary Health
2
Rapid Response
1
Natural Hazards
1
Polio
1
A lack of knowledge about the threat of vaccine-preventable diseases, risks and benefits of vaccines, mistrust of government and health workers, poor service delivery and alternative health or religious beliefs play a role in lower uptake of some vaccines. These challenges underscore the importance ...
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
News Release 11 april 2022
Self-care interventions are evidence-based, quality drugs, devices, diagnostics and/or digital products which can be provided fully or partially outside of formal health services and can be used with or without the direct supervision of health care personnel.
Where HPV tests are available as part o...
Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin...
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine safety, use of a network of distributed data ...
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inextricably linked. Women living with HIV are six times more likely to develop cervical cancer, which is o...
This fact sheet is based on a systematic review of the literature on HPV and cervical cancer epidemiology, and a survey on policies and practices related to the prevention and control of cervical cancer among women living with HIV (WLHIV) to PAHO Member States. It details scorecards on the advances ...
Cervical cancer is a disease of the female reproductive tract caused primarily by oncogenic types of human papillomavirus
(HPV). In 2020, it was the fourth most common cancer among women worldwide, with an estimated 604 000 new cases and 342 000 deaths
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
This Plan envisions a future with the elimination of cervical cancer as a public health problem as a result of universal access to sexual health and STI prevention services, HPV vaccines, effective screening and precancer treatment services, treatment of invasive cervical cancer, and palliative care...
Cervical Cancer Control in India
recommended
A new e-learning course has just been released, aimed at healthcare professionals working with patients in India exploring HPV screening and vaccination, assessment and diagnosis of cervical cancer, and palliative care for patients with advanced cervical cancer. The course was developed by ecancer i...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life course from childhood through to adulthood. These inclu...
Guía de prácticas esenciales. Segunda edición
Se sabe desde hace tiempo que las mujeres con el VIH presentan un mayor riesgo de desarrollar cáncer cervicouterino; sin embargo, existen pocos datos e información sobre esta afección en la Región de las Américas. Este estudio, realizado entre el 2019 y el 2020, intenta brindar información y d...
Esta carpeta ofrece información básica acerca de la estrategia de tamizaje basada en el test de VPH. Tiene como principales destinatariosa los integrantes del equipo de salud que realizan las tomas de las muestras para el tamizaje en las provincias que incorporaron esta nueva tecnología [ginecól...
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
